Patients and carers
Our mission is to make a positive difference to the lives of the individuals, carers and families who are affected by neurodegenerative diseases
We are drawing on decades of scientific, clinical and healthcare experience to understand the progression of Alzheimer’s disease, frontotemporal dementia and other neurodegenerative diseases to develop an effective treatment.
Alzheimer’s today
As the world’s population ages, the prevalence of the disease is predicted to reach epidemic proportions.
Mild cognitive impairment
MCI is not a normal part of ageing, and understanding the difference is critical to getting an early diagnosis, and the right kind of support.
Alzheimer’s disease
There is currently no treatment to prevent or delay the onset of Alzheimer’s, nor to slow down or stop its progression. Our new drug could change this prognosis, potentially improving the lives of millions.
Frontotemporal dementia
This less common type of dementia can lead to personality changes and difficulties with speech and movement, often developing at a younger age than other types.
Education, advocacy and resources
Read about our enduring focus on education, our ongoing work with GT Diagnostic Centre, and the important role played by patient advocacy groups across the world.